vs
DILLARD'S, INC.(DDS)与Rollins, Inc.(ROL)财务数据对比。点击上方公司名可切换其他公司
DILLARD'S, INC.的季度营收约是Rollins, Inc.的1.6倍($1.5B vs $906.4M),Rollins, Inc.净利率更高(11.9% vs 8.8%,领先3.1%),Rollins, Inc.同比增速更快(10.2% vs 2.9%),DILLARD'S, INC.自由现金流更多($156.2M vs $111.2M),过去两年Rollins, Inc.的营收复合增速更高(0.8% vs -16.9%)
Dillard's, Inc.是美国知名连锁百货企业,1938年由威廉·T·迪拉德创立,总部位于阿肯色州小石城,目前在全美30个州运营约272家门店,其中得克萨斯州、佛罗里达州分别设有57家、42家门店,为其门店数量最多的两个区域。
Rollins, Inc.是北美知名虫害防治服务商,面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务,覆盖北美、英国等市场,在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
DDS vs ROL — 直观对比
营收规模更大
DDS
是对方的1.6倍
$906.4M
营收增速更快
ROL
高出7.3%
2.9%
净利率更高
ROL
高出3.1%
8.8%
自由现金流更多
DDS
多$44.9M
$111.2M
两年增速更快
ROL
近两年复合增速
-16.9%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.5B | $906.4M |
| 净利润 | $129.8M | $107.8M |
| 毛利率 | 43.4% | — |
| 营业利润率 | 11.5% | 16.1% |
| 净利率 | 8.8% | 11.9% |
| 营收同比 | 2.9% | 10.2% |
| 净利润同比 | 4.2% | 2.5% |
| 每股收益(稀释后) | $8.31 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DDS
ROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.5B | $912.9M | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $999.5M | ||
| Q1 25 | $2.0B | $822.5M | ||
| Q4 24 | $1.4B | $832.2M | ||
| Q3 24 | $1.5B | $916.3M | ||
| Q2 24 | $1.5B | $891.9M |
净利润
DDS
ROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $129.8M | $116.4M | ||
| Q3 25 | $72.8M | $163.5M | ||
| Q2 25 | $163.8M | $141.5M | ||
| Q1 25 | $214.4M | $105.2M | ||
| Q4 24 | $124.6M | $105.7M | ||
| Q3 24 | $74.5M | $136.9M | ||
| Q2 24 | $180.0M | $129.4M |
毛利率
DDS
ROL
| Q1 26 | — | — | ||
| Q4 25 | 43.4% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 43.9% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 42.6% | — | ||
| Q3 24 | 37.6% | — | ||
| Q2 24 | 44.6% | — |
营业利润率
DDS
ROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 11.5% | 17.5% | ||
| Q3 25 | 6.2% | 21.9% | ||
| Q2 25 | 14.0% | 19.8% | ||
| Q1 25 | 11.7% | 17.3% | ||
| Q4 24 | 11.4% | 18.1% | ||
| Q3 24 | 6.5% | 20.9% | ||
| Q2 24 | 15.2% | 20.4% |
净利率
DDS
ROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 8.8% | 12.8% | ||
| Q3 25 | 4.8% | 15.9% | ||
| Q2 25 | 10.7% | 14.2% | ||
| Q1 25 | 10.6% | 12.8% | ||
| Q4 24 | 8.7% | 12.7% | ||
| Q3 24 | 5.0% | 14.9% | ||
| Q2 24 | 11.6% | 14.5% |
每股收益(稀释后)
DDS
ROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $8.31 | $0.24 | ||
| Q3 25 | $4.66 | $0.34 | ||
| Q2 25 | $10.39 | $0.29 | ||
| Q1 25 | $13.41 | $0.22 | ||
| Q4 24 | $7.73 | $0.22 | ||
| Q3 24 | $4.59 | $0.28 | ||
| Q2 24 | $11.09 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $2.0B | $1.4B |
| 总资产 | $4.3B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势,按日历期对齐
现金及短期投资
DDS
ROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $1.1B | $100.0M | ||
| Q3 25 | $1.0B | $127.4M | ||
| Q2 25 | $900.5M | $123.0M | ||
| Q1 25 | $717.9M | $201.2M | ||
| Q4 24 | $980.4M | $89.6M | ||
| Q3 24 | $946.7M | $95.3M | ||
| Q2 24 | $817.8M | $106.7M |
总债务
DDS
ROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
DDS
ROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.0B | $1.4B | ||
| Q3 25 | $1.9B | $1.5B | ||
| Q2 25 | $1.9B | $1.4B | ||
| Q1 25 | $1.8B | $1.4B | ||
| Q4 24 | $2.0B | $1.3B | ||
| Q3 24 | $1.9B | $1.3B | ||
| Q2 24 | $1.9B | $1.2B |
总资产
DDS
ROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $4.3B | $3.1B | ||
| Q3 25 | $3.7B | $3.2B | ||
| Q2 25 | $3.9B | $3.2B | ||
| Q1 25 | $3.5B | $2.9B | ||
| Q4 24 | $4.1B | $2.8B | ||
| Q3 24 | $3.7B | $2.8B | ||
| Q2 24 | $3.9B | $2.8B |
负债/权益比
DDS
ROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $186.5M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $156.2M | $111.2M |
| 自由现金流率自由现金流/营收 | 10.6% | 12.3% |
| 资本支出强度资本支出/营收 | 2.1% | 0.8% |
| 现金转化率经营现金流/净利润 | 1.44× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $781.3M | $621.1M |
8季度趋势,按日历期对齐
经营现金流
DDS
ROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $186.5M | $164.7M | ||
| Q3 25 | $86.8M | $191.3M | ||
| Q2 25 | $232.6M | $175.1M | ||
| Q1 25 | $364.7M | $146.9M | ||
| Q4 24 | $173.5M | $188.2M | ||
| Q3 24 | $-68.4M | $146.9M | ||
| Q2 24 | $244.4M | $145.1M |
自由现金流
DDS
ROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $156.2M | $159.0M | ||
| Q3 25 | $60.1M | $182.8M | ||
| Q2 25 | $215.8M | $168.0M | ||
| Q1 25 | $349.3M | $140.1M | ||
| Q4 24 | $145.4M | $184.0M | ||
| Q3 24 | $-94.3M | $139.4M | ||
| Q2 24 | $209.2M | $136.4M |
自由现金流率
DDS
ROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 10.6% | 17.4% | ||
| Q3 25 | 4.0% | 17.8% | ||
| Q2 25 | 14.1% | 16.8% | ||
| Q1 25 | 17.3% | 17.0% | ||
| Q4 24 | 10.2% | 22.1% | ||
| Q3 24 | -6.3% | 15.2% | ||
| Q2 24 | 13.5% | 15.3% |
资本支出强度
DDS
ROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 2.1% | 0.6% | ||
| Q3 25 | 1.8% | 0.8% | ||
| Q2 25 | 1.1% | 0.7% | ||
| Q1 25 | 0.8% | 0.8% | ||
| Q4 24 | 2.0% | 0.5% | ||
| Q3 24 | 1.7% | 0.8% | ||
| Q2 24 | 2.3% | 1.0% |
现金转化率
DDS
ROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 1.44× | 1.41× | ||
| Q3 25 | 1.19× | 1.17× | ||
| Q2 25 | 1.42× | 1.24× | ||
| Q1 25 | 1.70× | 1.40× | ||
| Q4 24 | 1.39× | 1.78× | ||
| Q3 24 | -0.92× | 1.07× | ||
| Q2 24 | 1.36× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图